Kliniske studier for Migrene i Arkansas
3 studier for Migrene søker deltakere på steder i Arkansas.
Byer i Arkansas
Offisiell studietekst (engelsk)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Preferred Research Partners /ID# 270389, Little Rock
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06810505Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- HealthStar Research Glenwood /ID# 275303, Glenwood
- HealthStar Research of Hot Springs /ID# 273256, Hot Springs
- Preferred Research Partners /ID# 230725, Little Rock
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Arkansas Clinical Research, Little Rock
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07645924Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.